p.88 抽出テキスト
684. McClure GR, Belley-Cote EP, Jaffer IH, Dvirnik N, An KR, Fortin G, et al. Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace 2018;20:1442–50. https://doi.org/10.1093/europace/eux336 685. Phan K, Xie A, La Meir M, Black D, Yan TD. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart 2014;100:722–30. https://doi.org/10.1136/heartjnl-2013-305351 686. Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg 2006;131:1029–35. https://doi.org/10.1016/j. jtcvs.2005.10.020 687. Gillinov AM, Gelijns AC, Parides MK, DeRose JJ, Jr, Moskowitz AJ, Voisine P, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med 2015; 372:1399–409. https://doi.org/10.1056/NEJMoa1500528 688. MacGregor RM, Bakir NH, Pedamallu H, Sinn LA, Maniar HS, Melby SJ, et al. Late results after stand-alone surgical ablation for atrial fibrillation. J Thorac Cardiovasc Surg 2022;164:1515–1528.e8. https://doi.org/10.1016/j.jtcvs.2021.03.109 689. Musharbash FN, Schill MR, Sinn LA, Schuessler RB, Maniar HS, Moon MR, et al. Performance of the Cox-Maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery. J Thorac Cardiovasc Surg 2018;155:159–70. https://doi.org/10.1016/j.jtcvs.2017.09.095 690. Rankin JS, Lerner DJ, Braid-Forbes MJ, McCrea MM, Badhwar V. Surgical ablation of atrial fibrillation concomitant to coronary-artery bypass grafting provides costeffective mortality reduction. J Thorac Cardiovasc Surg 2020;160:675–686 e13. https://doi.org/10.1016/j.jtcvs.2019.07.131 691. Suwalski P, Kowalewski M, Jasinski M, Staromlynski J, Zembala M, Widenka K, et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK). J Thorac Cardiovasc Surg 2019;157:1007–1018 e4. https://doi.org/10.1016/j.jtcvs.2018.07.099 692. Suwalski P, Kowalewski M, Jasinski M, Staromlynski J, Zembala M, Widenka K, et al. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery. Eur J Cardiothorac Surg 2020;57:691–700. https://doi.org/10.1093/ejcts/ezz298 693. Wehbe M, Albert M, Lewalter T, Ouarrak T, Senges J, Hanke T, et al. The German cardiosurgery atrial fibrillation registry: 1-year follow-up outcomes. Thorac Cardiovasc Surg 2023;71:255–63. https://doi.org/10.1055/s-0042-1750311 694. Kim HJ, Kim YJ, Kim M, Yoo JS, Kim DH, Park DW, et al. Surgical ablation for atrial fibrillation during aortic and mitral valve surgery: a nationwide population-based cohort study. J Thorac Cardiovasc Surg 2024;167:981–93. https://doi.org/10.1016/j.jtcvs. 2022.08.038 695. Ad N, Henry L, Hunt S, Holmes SD. Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery? J Thorac Cardiovasc Surg 2012;143:936–44. https://doi.org/10.1016/j.jtcvs.2011. 12.018 696. Maesen B, van der Heijden CAJ, Bidar E, Vos R, Athanasiou T, Maessen JG. Patient-reported quality of life after stand-alone and concomitant arrhythmia surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 2022;34:339–48. https://doi.org/10.1093/icvts/ivab282 697. Osmancik P, Budera P, Talavera D, Hlavicka J, Herman D, Holy J, et al. Five-year outcomes in cardiac surgery patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation. The long-term follow-up of the PRAGUE-12 study. Heart Rhythm 2019;16:1334–40. https://doi.org/10.1016/j.hrthm.2019.05.001 698. Lee R, Jivan A, Kruse J, McGee EC, Jr, Malaisrie SC, Bernstein R, et al. Late neurologic events after surgery for atrial fibrillation: rare but relevant. Ann Thorac Surg 2013;95: 126–31; discussion 131–2. https://doi.org/10.1016/j.athoracsur.2012.08.048 699. Kowalewski M, Pasierski M, Kołodziejczak M, Litwinowicz R, Kowalówka A, Wańha W, et al. Atrial fibrillation ablation improves late survival after concomitant cardiac surgery. J Thorac Cardiovasc Surg 2023;166:1656–1668.e8. https://doi.org/10.1016/j.jtcvs.2022. 04.035 700. Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg 1999;118:833–40. https://doi.org/10. 1016/S0022-5223(99)70052-8 701. Huffman MD, Karmali KN, Berendsen MA, Andrei AC, Kruse J, McCarthy PM, et al. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. Cochrane Database Syst Rev 2016;8:CD011814. https://doi.org/10.1002/14651858. CD011814.pub2 702. Kowalewski M, Pasierski M, Finke J, Kolodziejczak M, Staromlynski J, Litwinowicz R, et al. Permanent pacemaker implantation after valve and arrhythmia surgery in patients with preoperative atrial fibrillation. Heart Rhythm 2022;19:1442–9. https://doi.org/10. 1016/j.hrthm.2022.04.007 703. Pokushalov E, Romanov A, Corbucci G, Cherniavsky A, Karaskov A. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study. Eur J Cardiothorac Surg 2012;41:556–60. https://doi.org/10.1093/ejcts/ ezr101 704. Yoo JS, Kim JB, Ro SK, Jung Y, Jung SH, Choo SJ, et al. Impact of concomitant surgical atrial fibrillation ablation in patients undergoing aortic valve replacement. Circ J 2014; 78:1364–71. https://doi.org/10.1253/circj.CJ-13-1533 705. Malaisrie SC, Lee R, Kruse J, Lapin B, Wang EC, Bonow RO, et al. Atrial fibrillation ablation in patients undergoing aortic valve replacement. J Heart Valve Dis 2012;21: 350–7. 706. Rankin JS, Lerner DJ, Braid-Forbes MJ, Ferguson MA, Badhwar V. One-year mortality and costs associated with surgical ablation for atrial fibrillation concomitant to coronary artery bypass grafting. Eur J Cardiothorac Surg 2017;52:471–7. https://doi.org/10. 1093/ejcts/ezx126 707. Schill MR, Musharbash FN, Hansalia V, Greenberg JW, Melby SJ, Maniar HS, et al. Late results of the Cox-Maze IV procedure in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2017;153:1087–94. https://doi.org/10.1016/j.jtcvs. 2016.12.034 708. Gupta D, Ding WY, Calvert P, Williams E, Das M, Tovmassian L, et al. Cryoballoon pulmonary vein isolation as first-line treatment for typical atrial flutter. Heart 2023; 109:364–71. https://doi.org/10.1136/heartjnl-2022-321729 709. Steinberg C, Champagne J, Deyell MW, Dubuc M, Leong-Sit P, Calkins H, et al. Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the cryoballoon vs irrigated radiofrequency catheter ablation (CIRCA-DOSE) study. Heart Rhythm 2021;18:1463–70. https://doi.org/10.1016/j.hrthm.2021.06.1172 710. Heijman J, Linz D, Schotten U. Dynamics of atrial fibrillation mechanisms and comorbidities. Annu Rev Physiol 2021;83:83–106. https://doi.org/10.1146/annurevphysiol-031720-085307 711. Fabritz L, Crijns H, Guasch E, Goette A, Hausler KG, Kotecha D, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA consensus conference. Europace 2021;23:329–44. https://doi.org/10. 1093/europace/euaa279 712. Brandes A, Smit MD, Nguyen BO, Rienstra M, Van Gelder IC. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev 2018;7:118–27. https://doi.org/10. 15420/aer.2018.18.2 713. Pokorney SD, Cocoros N, Al-Khalidi HR, Haynes K, Li S, Al-Khatib SM, et al. Effect of mailing educational material to patients with atrial fibrillation and their clinicians on use of oral anticoagulants: a randomized clinical trial. JAMA Netw Open 2022;5:e2214321. https://doi.org/10.1001/jamanetworkopen.2022.14321 714. Ritchie LA, Penson PE, Akpan A, Lip GYH, Lane DA. Integrated care for atrial fibrillation management: the role of the pharmacist. Am J Med 2022;135:1410–26. https://doi. org/10.1016/j.amjmed.2022.07.014 715. Guo Y, Guo J, Shi X, Yao Y, Sun Y, Xia Y, et al. Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial longterm extension cohort. Eur J Intern Med 2020;82:105–11. https://doi.org/10.1016/j. ejim.2020.09.024 716. Yan H, Du YX, Wu FQ, Lu XY, Chen RM, Zhang Y. Effects of nurse-led multidisciplinary team management on cardiovascular hospitalization and quality of life in patients with atrial fibrillation: randomized controlled trial. Int J Nurs Stud 2022;127:104159. https://doi.org/10.1016/j.ijnurstu.2021.104159 717. Stewart S, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet 2015;385:775–84. https://doi.org/10.1016/S0140-6736(14)61992-9 718. Cox JL, Parkash R, Foster GA, Xie F, MacKillop JH, Ciaccia A, et al. Integrated management program advancing community treatment of atrial fibrillation (IMPACT-AF): a cluster randomized trial of a computerized clinical decision support tool. Am Heart J 2020;224:35–46. https://doi.org/10.1016/j.ahj.2020.02.019 719. Sposato LA, Stirling D, Saposnik G. Therapeutic decisions in atrial fibrillation for stroke prevention: the role of aversion to ambiguity and physicians’ risk preferences. J Stroke Cerebrovasc Dis 2018;27:2088–95. https://doi.org/10.1016/j.jstrokecerebrovasdis. 2018.03.005 720. Noseworthy PA, Brito JP, Kunneman M, Hargraves IG, Zeballos-Palacios C, Montori VM, et al. Shared decision-making in atrial fibrillation: navigating complex issues in partnership with the patient. J Interv Card Electrophysiol 2019;56:159–63. https://doi.org/10. 1007/s10840-018-0465-5 721. Poorcheraghi H, Negarandeh R, Pashaeypoor S, Jorian J. Effect of using a mobile drug management application on medication adherence and hospital readmission among elderly patients with polypharmacy: a randomized controlled trial. BMC Health Serv Res 2023;23:1192. https://doi.org/10.1186/s12913-023-10177-4 722. Kotecha D, Chua WWL, Fabritz L, Hendriks J, Casadei B, Schotten U, et al. European Society of Cardiology (ESC) Atrial Fibrillation Guidelines Taskforce, the CATCH ME consortium, and the European Heart Rhythm Association (EHRA). European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers. Europace 2018;20:225–33. https://doi.org/10. 1093/europace/eux299 723. Bunting KV, Gill SK, Sitch A, Mehta S, O’Connor K, Lip GY, et al. Improving the diagnosis of heart failure in patients with atrial fibrillation. Heart 2021;107:902–8. https:// doi.org/10.1136/heartjnl-2020-318557 724. Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, et al. EACVI/EHRA expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging 2016;17:355–83. https:// doi.org/10.1093/ehjci/jev354 ESC Guidelines 3401 Downloaded from academic.oup.com/eurheartj/article/45/36/3314/7738779 by guest on 07 October 2026